BIOTRONIK, Vascular Intervention - Introducing Pulsar-18: The World's First 4 F-compatible Self-expanding Stent With Lengths Up to 200 mm

Published: Nov 10, 2010

BUELACH, Switzerland--(BUSINESS WIRE)--BIOTRONIK AG, a European manufacturer of therapy solutions for vascular intervention, has announced the international full market release of the innovative Pulsar-18 stent for treatment of long lesions in the superficial femoral and infrapopliteal arteries. Pulsar-18 is unique in the market, representing an advance in technology that further reinforces the company’s position as a leader in providing high quality technologies for patients with peripheral vascular disease.

Back to news